# US 2023/0266304 A1 · Obese ferret model and methods of establishing and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0266304 A1
- Document ID: US20230266304A1
- Status: Published application
- Kind: A1
- Application number: 18/005,105
- Filed: 2021-07-12
- Published: 2023-08-24
- Earliest claimed: 2020-07-15
- Assignees: St. Jude Children's Research Hospital
- Applicants: St. Jude Children's Research Hospital, Inc.
- Inventors: Stacey SCHULTZ-CHERRY; Victoria MELIOPOULOS; Rebekah HONCE
- Web page: https://patentgrep.com/patent/US20230266304A1

## CPC

- G01N 33/5088: {of vertebrates}
- G01N 2333/11: Orthomyxoviridae, e.g. influenza virus
- G01N 2333/165: Coronaviridae, e.g. avian infectious bronchitis virus
- G01N 2333/46: from vertebrates
- G01N 2800/044: Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
- G01N 2800/12: Pulmonary diseases
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for establishing an obese ferret model by feeding a ferret with a diet having at least 25% of carbohydrate content for a period of time to provide the obese ferret model is disclosed as is a method of using said model to screen a substance for treating a respiratory infection.

## Claims

### Claim 1

A method for establishing an obese ferret model comprising feeding a ferret with a diet having at least 25% of carbohydrate content for a period of time to provide the obese ferret model.

### Claim 2 (depends on 1)

The method of claim 1, wherein the obese ferret model exhibits at least one of visceral adiposity, hyperglycemia, or reduced high-density lipoprotein cholesterol compared to a control ferret.

### Claim 3 (depends on 1)

The method of claim 1, wherein the obese ferret model does not develop insulinoma.

### Claim 4 (depends on 1)

An obese ferret model established by the method of claim 1.

### Claim 5 (depends on 4)

The obese ferret model of claim 4, wherein said obese ferret model exhibits at least one of visceral adiposity, hyperglycemia, or reduced high-density lipoprotein cholesterol levels compared to a control ferret.

### Claim 6 (depends on 4)

The obese ferret model of claim 4, wherein said obese ferret model does not develop insulinoma.

### Claim 7

A method for screening a substance for treating a respiratory infection comprising,
providing a test substance to an obese ferret model and a control ferret either before or after infecting the obese ferret model and a control ferret with an infectious agent that causes a respiratory infection; and
determining whether the test substance treats the respiratory infection.

### Claim 8 (depends on 7)

The method of claim 7, wherein the obese ferret model exhibits at least one of visceral adiposity, hyperglycemia, or reduced high-density lipoprotein cholesterol levels compared to a control ferret.

### Claim 9 (depends on 7)

The method of claim 7, wherein the infectious agent that causes a respiratory infection is a bacterium, fungus or virus.

### Claim 10 (depends on 9)

The method of claim 9, wherein the virus is an influenza virus or coronavirus.
